Skip to content

Joseph S. Raccuia, M.D.

NPI 1013961309ActiveIndividual· Surgery, Surgical Oncology· Hoboken, NJ

Surgery, Surgical Oncology (M.D.) in Hoboken, New Jersey, licensed in NY and NJ, with an NPI issued in May 2006. Part D covered 65 prescriptions written in 2024, 71% of them generic. Telix Pharmaceuticals was the largest of 2 companies reporting payments in 2025, $143.53 in all, mostly food and beverage.

Overview

NPI1013961309
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorYes
NPI issuedMay 20, 2006
Last updated in NPPESDec 14, 2016

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)65 · 66 30-day fills
Total drug cost$3,556
Generic share71% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$143.53 · 3 payments from 2 companies
  • 2024$285.61 · 4 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Telix Pharmaceuticals$73.931
Axogen$69.602

What the 2025 payments were for

  • Food and Beverage$143.53 · 3 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Surgery, Surgical Oncology providers in Hoboken

All Surgery, Surgical Oncology providers in New Jersey